The management of ovarian cancer: COSA clinical trial.
D000477:Alkylating Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000628:therapy*
D000477:Alkylating Agents